• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy
  • Reports
    • Diabetes Technology Innovations Special Report
    • Continuous Glucose Monitoring (CGM) Market Report

Dexcom

Dexcom, RxFood partner on AI-based nutrition, glucose monitoring for diabetes management

September 22, 2023 By Sean Whooley

Dexcom RxFood CGM data

Dexcom (Nasdaq:DXCM) announced that it teamed up with RxFood on a digital diabetes solution for people in Canada. The first-of-its-kind partnership combines Dexcom’s continuous glucose monitoring (CGM) with RxFood’s AI-driven personalized nutrition assessments. The companies aim to introduce an improved digital health solution for people living with diabetes. It integrates food data with insulin dosing, […]

Filed Under: Business/Financial News, Diabetes, Featured, Patient Monitoring, Technology Tagged With: Dexcom

Dexcom One CGM sensor launches in France with reimbursement

September 15, 2023 By Sean Whooley

Dexcom One

Dexcom (Nasdaq:DXCM) recently announced the availability of its Dexcom One real-time continuous glucose monitor (CGM) in France. The availability of the real-time CGM sensor comes via reimbursement. It brings the technology to half a million more people with diabetes in France. The company secured access to the platform for all patients two years and older […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Technology Tagged With: Dexcom

Analysts: GLP-1 drugs should have minor impact on insulin pump market — but will boost CGMs

September 8, 2023 By Sean Whooley

American Diabetes Association ADA 2023 Medtronic MiniMed 780G Insulet Omnipod 5 Senseonics Eversense E3 GLP-1s

Based on conversations with diabetes experts, analysts are playing down the potentially negative impact of GLP-1 receptor agonists on the diabetes technology industry. The GLP-1 drug class, which includes Ozempic and Wegovy, has cast a shadow of doubt over diabetes technology of late. This therapeutic class, a glucagon-like peptide 1, has proven to lead to […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Pharmaceuticals, Technology, Wall Street Beat Tagged With: abbott, Dexcom, GLP-1s, Insulet, Medtronic, Senseonics

Dexcom appoints a new board director

August 28, 2023 By Sean Whooley

Rimma Driscoll Zoetis Dexcom

Dexcom (Nasdaq:DXCM) announced today that it appointed Rimma Driscoll to its board of directors. The San Diego-based continuous glucose monitor (CGM) maker made Driscoll’s appointment effective on Aug. 24. She currently serves as EVP and head of global strategy, commercial and business development and global biodevices for Zoetis. At Zoetis, a leading animal health company […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Personnel, Technology Tagged With: Dexcom, Personnel, Personnel Moves

Dexcom more than doubles profits on 25% sales growth in Q2

July 28, 2023 By Sean Whooley

Dexcom updated logo

Dexcom (Nasdaq:DXCM) shares are up today on second-quarter results that topped the consensus forecast. Shares of DXCM rose 2.3% at $132.35 apiece after the market closed yesterday. By the next afternoon, DXCM shares were up more than 4% to $134.71 apiece.  MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, MassDevice Earnings Roundup, Patient Monitoring, Technology, Wall Street Beat Tagged With: Dexcom

Dexcom CCO Teri Lawver says new sensor is ‘first step’ to expand addressable market

July 5, 2023 By Sean Whooley

Teri Lawver Dexcom CCO

Teri Lawver joined Dexcom (Nasdaq:DXCM) as chief commercial officer just as the company got set for a massive commercial undertaking. The FDA cleared the company’s next-generation Dexcom G7 continuous glucose monitor (CGM) in December 2022. One month later, Lawver assumed the position of CCO. Within about a month, she was set to oversee the U.S. launch […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Technology Tagged With: ADA 2023, Dexcom

The biggest stories from the American Diabetes Association (ADA) 2023 Scientific Sessions

June 30, 2023 By Sean Whooley

American Diabetes Association ADA 2023 Medtronic MiniMed 780G Insulet Omnipod 5 Senseonics Eversense E3 GLP-1s

As it does every year, this past week, the American Diabetes Association convened its Scientific Sessions to bring together leaders in the diabetes space. At last year’s event, next-generation technologies from the big hitters took the spotlight. The 83rd iteration this past week produced a range of new studies, product updates and positive news for […]

Filed Under: Business/Financial News, Clinical Trials, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Pediatrics, Pharmaceuticals, Surgical, Technology, Wall Street Beat Tagged With: abbott, ADA 2023, American Diabetes Association, Bigfoot Biomedical, Dexcom, Eli Lilly & Co., Fractyl Health, Insulet, Medtronic, Novo Nordisk, Senseonics, Sernova Inc, Vida Health, Virta Health

Dexcom aims to bring new glucose sensor to the market for people who don’t use insulin

June 23, 2023 By Sean Whooley

Dexcom updated logo

Dexcom (Nasdaq:DXCM) today unveiled its strategy to expand access to its glucose-sensing technology for millions around the world. San Diego-based Dexcom held an Investor Day event in which it revealed plans to bring a new product to market in the U.S. in 2024. The company designed its new product for people who don’t use insulin […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Technology Tagged With: ADA 2023, American Diabetes Association, Dexcom

Dexcom study shows diabetes’ impact on mental health

June 12, 2023 By Sean Whooley

Dexcom G6 in action

A new study commissioned by Dexcom (Nasdaq:DXCM) found that diabetes has significant negative effects on mental health. The study revealed that 84% of people surveyed agree that having diabetes can negatively impact mental health. It also demonstrated that nearly all participants (91%) believe technology enables a balanced lifestyle while managing diabetes. Dexcom, a maker of […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Technology Tagged With: Dexcom

Dexcom touts more clinical evidence for G6 CGM in Japan

May 12, 2023 By Sean Whooley

Dexcom G6

Dexcom (Nasdaq:DXCM) announced that it showcased its Dexcom G6 CGM at the 66th Annual Meeting of the Japan Diabetes Society. G6, now the previous-generation version of the company’s CGM after the launch of the G7, uses a small, wearable sensor. It also features a transmitter, continuously measuring and sending glucose levels wirelessly to a smart […]

Filed Under: Clinical Trials, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Technology Tagged With: Dexcom

  • « Go to Previous Page
  • Page 1
  • Interim pages omitted …
  • Page 13
  • Page 14
  • Page 15
  • Page 16
  • Page 17
  • Interim pages omitted …
  • Page 24
  • Go to Next Page »

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.
MDO

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
About
Contact us
Listen to our Weekly Podcasts
Advertise

Copyright © 2026 · Arrowfly LLC. All Rights Reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy | Terms & Conditions | RSS